Skip to content
About Us
About
Our Team
Board of Directors
Leadership Team
Scientific Advisory Board
Partners
Join Us
Our Focus
Overview
What are cell and gene therapies?
Chronic limb-threatening ischemia
CD19 hematological malignancies
Our Science
Overview
Multi-cell therapies (MCTs)
Targeted nanoparticles (TNP)
Clinical trials
Our Pipeline
Patients
About
Participate in
our Trials
Resources
News and Media
Contact Us
Professor Keith Harding CBE FRCGP FRCP FRCS
Professor Keith Harding CBE FRCGP FRCP FRCS
innovative cell therapies
Contact us
